102 related articles for article (PubMed ID: 8053406)
1. Interleukin-6 antisense deoxyoligonucleotides inhibit bone resorption by giant cells from human giant cell tumors of bone.
Reddy SV; Takahashi S; Dallas M; Williams RE; Neckers L; Roodman GD
J Bone Miner Res; 1994 May; 9(5):753-7. PubMed ID: 8053406
[TBL] [Abstract][Full Text] [Related]
2. Evidence for an autocrine/paracrine role for interleukin-6 in bone resorption by giant cells from giant cell tumors of bone.
Ohsaki Y; Takahashi S; Scarcez T; Demulder A; Nishihara T; Williams R; Roodman GD
Endocrinology; 1992 Nov; 131(5):2229-34. PubMed ID: 1425421
[TBL] [Abstract][Full Text] [Related]
3. Human cord blood monocytes undergo terminal osteoclast differentiation in vitro in the presence of culture medium conditioned by giant cell tumor of bone.
Roux S; Quinn J; Pichaud F; Orcel P; Chastre E; Jullienne A; De Vernejoul MC
J Cell Physiol; 1996 Sep; 168(3):489-98. PubMed ID: 8816903
[TBL] [Abstract][Full Text] [Related]
4. Osteoclasts constitutively express regulators of bone resorption: an immunohistochemical and in situ hybridization study.
O'Keefe RJ; Teot LA; Singh D; Puzas JE; Rosier RN; Hicks DG
Lab Invest; 1997 Apr; 76(4):457-65. PubMed ID: 9111508
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of a cDNA clone encoding a novel peptide (OSF) that enhances osteoclast formation and bone resorption.
Reddy S; Devlin R; Menaa C; Nishimura R; Choi SJ; Dallas M; Yoneda T; Roodman GD
J Cell Physiol; 1998 Dec; 177(4):636-45. PubMed ID: 10092216
[TBL] [Abstract][Full Text] [Related]
6. New model for bone resorption study in vitro: human osteoclast-like cells from giant cell tumors of bone.
Grano M; Colucci S; De Bellis M; Zigrino P; Argentino L; Zambonin G; Serra M; Scotlandi K; Teti A; Zambonin Zallone A
J Bone Miner Res; 1994 Jul; 9(7):1013-20. PubMed ID: 7942147
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6 messenger RNA expression and interleukin-6 protein secretion in cells isolated from normal human bone: regulation by interleukin-1.
Linkhart TA; Linkhart SG; MacCharles DC; Long DL; Strong DD
J Bone Miner Res; 1991 Dec; 6(12):1285-94. PubMed ID: 1792940
[TBL] [Abstract][Full Text] [Related]
8. A useful method to evaluate bone resorption inhibitors, using osteoclast-like multinucleated cells.
Sugawara K; Hamada M; Hosoi S; Tamaoki T
Anal Biochem; 1998 Jan; 255(2):204-10. PubMed ID: 9451505
[TBL] [Abstract][Full Text] [Related]
9. The effect of interleukin-6 and soluble interleukin-6 receptor protein on the bone resorptive activity of human osteoclasts generated in vitro.
Flanagan AM; Stow MD; Williams R
J Pathol; 1995 Jul; 176(3):289-97. PubMed ID: 7674091
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 antisense oligonucleotides inhibit the growth of human myeloma cell lines.
Levy Y; Tsapis A; Brouet JC
J Clin Invest; 1991 Aug; 88(2):696-9. PubMed ID: 1864979
[TBL] [Abstract][Full Text] [Related]
11. Cytological properties of stromal cells derived from giant cell tumor of bone (GCTSC) which can induce osteoclast formation of human blood monocytes without cell to cell contact.
Nishimura M; Yuasa K; Mori K; Miyamoto N; Ito M; Tsurudome M; Nishio M; Kawano M; Komada H; Uchida A; Ito Y
J Orthop Res; 2005 Sep; 23(5):979-87. PubMed ID: 16024207
[TBL] [Abstract][Full Text] [Related]
12. In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis.
Most W; Schot L; Ederveen A; van der Wee-Pals L; Papapoulos S; Löwik C
J Bone Miner Res; 1995 Oct; 10(10):1523-30. PubMed ID: 8686508
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide: a cytokine-induced regulator of bone resorption.
Ralston SH; Ho LP; Helfrich MH; Grabowski PS; Johnston PW; Benjamin N
J Bone Miner Res; 1995 Jul; 10(7):1040-9. PubMed ID: 7484279
[TBL] [Abstract][Full Text] [Related]
14. Oligonucleotides antisense to the interleukin 1 receptor mRNA block the effects of interleukin 1 in cultured murine and human fibroblasts and in mice.
Burch RM; Mahan LC
J Clin Invest; 1991 Oct; 88(4):1190-6. PubMed ID: 1833422
[TBL] [Abstract][Full Text] [Related]
15. Characterization of cells cultured from human giant-cell tumors of bone. Phenotypic relationship to the monocyte-macrophage and osteoclast.
Komiya S; Sasaguri Y; Inoue A; Nakashima M; Yamamoto S; Yanagida I; Morimatsu M
Clin Orthop Relat Res; 1990 Sep; (258):304-9. PubMed ID: 2168302
[TBL] [Abstract][Full Text] [Related]
16. Effect of IL-6 receptor antisense oligodeoxynucleotide on in vitro proliferation of myeloma cells.
Keller ET; Ershler WB
J Immunol; 1995 Apr; 154(8):4091-8. PubMed ID: 7706747
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue.
Lau YS; Sabokbar A; Gibbons CL; Giele H; Athanasou N
Hum Pathol; 2005 Sep; 36(9):945-54. PubMed ID: 16153456
[TBL] [Abstract][Full Text] [Related]
18. Functional and biochemical characterization of osteoclast-like cells derived from giant cell tumours of bone.
Grano M; Colucci S; Portoghese A; Zambonin G; Barattolo R; Serra M; Scotlandi K; Teti A; Zambonin Zallone A
Boll Soc Ital Biol Sper; 1992 Apr; 68(4):249-53. PubMed ID: 1463598
[TBL] [Abstract][Full Text] [Related]
19. Effects of synthetic peptido-leukotrienes on bone resorption in vitro.
Garcia C; Qiao M; Chen D; Kirchen M; Gallwitz W; Mundy GR; Bonewald LF
J Bone Miner Res; 1996 Apr; 11(4):521-9. PubMed ID: 8992883
[TBL] [Abstract][Full Text] [Related]
20. Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity.
Pederson L; Winding B; Foged NT; Spelsberg TC; Oursler MJ
Cancer Res; 1999 Nov; 59(22):5849-55. PubMed ID: 10582709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
